1-15 of 15
Ajoy L. Dias
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Matched Unrelated Donor Allogeneic Stem Cell Transplants with High CD34-Positive Cell Dose: A Single Center Experience

Zachary M. Avigan, Ajoy L. Dias, Denise Cummings, Richard L. Haspel
Journal: Blood
Blood (2022) 140 (Supplement 1): 10443–10444.
https://doi.org/10.1182/blood-2022-156392
Published: 2022
Journal Articles

Clonal Myeloid Disorders Following CAR T-Cell Therapy

Michael J. Andersen, Jr., Poorva Bindal, Phillip Michaels, Pavania Elavalakanar, Ajoy L. Dias, Jon E. Arnason, Rushad Patell
Journal: Blood
Blood (2022) 140 (Supplement 1): 10985–10986.
https://doi.org/10.1182/blood-2022-170430
Published: 2022
Journal Articles

A Phase 2 Randomized Study Comparing Venetoclax and Azacitidine to Conventional Induction Chemotherapy for Newly Diagnosed Fit Adults with Acute Myeloid Leukemia

Amir T. Fathi, Geoffrey G Fell, Areej El-Jawahri, Alexander E. Perl, Brian A. Jonas, Ajoy L. Dias, Alice S. Mims, Uma Borate, Brittany Knick Ragon, Michael R. Grunwald, Mary Linton B. Peters, Timothy A. Graubert, Philip C. Amrein, Hanno R. Hock, Andrew M. Brunner, Gabriela S. Hobbs, Rupa Narayan, Donna S. Neuberg, Ibrahim Aldoss
Journal: Blood
Blood (2022) 140 (Supplement 1): 3284–3286.
https://doi.org/10.1182/blood-2022-162525
Published: 2022
Journal Articles

Post-Transplant Vaccination with a Personalized Dendritic Cell/AML Fusion Cell Vaccine for Prevention of Relapse

Jessica J. Liegel, Poorva Bindal, Richard M. Stone, Robert J. Soiffer, Dina Stroopinsky, Giulia Cheloni, Lina Bisharat, Daniela Torres, Maryam Rahimian, Seo Yeon Yoo, Emma K. Logan, Pavania Elavalakanar, Hassan El Banna, Joshua Hauser, Anita G. Koshy, Rizwan Romee, Vincent T. Ho, Donna S. Neuberg, Yiwen Liu, Lourdes M. Mendez, Ajoy L. Dias, Benjamin L. Ebert, Donald Kufe, David Avigan, Jacalyn Rosenblatt
Journal: Blood
Blood (2021) 138 (Supplement 1): 2830.
https://doi.org/10.1182/blood-2021-154166
Published: 2021
Journal Articles

Non-Relapse Mortality in TP53 -Mutated MDS/AML - a Multi-Center Collaborative Study

Michael T. Byrne, Tony J Kurian, Dilan A Patel, Roni Tamari, Sanghee Hong, Haitham Abdelhakim, Victoria Klein, Patricio Rojas, Raksha Madhavan, Andrew Kent, Aaron C. Logan, Catherine J. Lee, Muhammad Husnain, Benjamin M Manning, Nicholas P. Tschernia, Ajoy L. Dias, Daniel Margalski, Benjamin Goldenson, Nathalie Byrne, Heidi Chen, Kseniya Petrova-Drus, Salyka M. Sengsayadeth, Aaron M Goodman, Dianna S. Howard, William A. Wood, Saar Gill, Antonio M. Jimenez, Jonathan A. Gutman, Lohith Gowda, Leland Metheny, III, Bhavana Bhatnagar, Betty K. Hamilton, Asmita Mishra, Michael R. Savona
Journal: Blood
Blood (2021) 138 (Supplement 1): 2922.
https://doi.org/10.1182/blood-2021-154151
Published: 2021
Journal Articles

Vaccination with a Personalized Dendritic Cell/AML Fusion Cell Vaccine Following Allogeneic Transplantation in a Phase 1 Clinical Trial

Jessica Liegel, MD, Richard M. Stone, MD, Robert J. Soiffer, MD, Dina Stroopinsky, PhD, Lina Bisharat, Maryam Rahimian, Emma Logan, Pavania Elavalakanar, MSc, BSc, Vincent T. Ho, MD, Rizwan Romee, MD, Donna S. Neuberg, ScD, Yiwen Liu, Lourdes M. Mendez, MD PhD, Ajoy L. Dias, MD, Poorva Bindal, MD, Anita Koshy, MD, Shira Orr, PhD, Daniela Torres, Giulia Cheloni, PhD, Benjamin L. Ebert, MDPhD, Donald Kufe, MD, David E. Avigan, MD, Jacalyn Rosenblatt, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10.
https://doi.org/10.1182/blood-2020-141634
Published: 2020
Journal Articles

Conditioning Regimen Intensity May Affect Outcome in MDS Patients Undergoing Allogeneic Stem Cell Transplantation, Depending on MDS Subgroup

Barry S. Skikne, MD, Anurag K. Singh, MD, Sunil Abhyankar, MD, Tara L. Lin, MD, Leyla Shune, MD, Neil Dunavin, MD, Ajoy L. Dias, MD, Brian McClune, DO, Abdulraheem Yacoub, MD, Clint Divine, Haitham Abdelhakim, MD, Siddhartha Ganguly, MD, Jennifer Hanses, Carol E Webb, BA, Joseph P. McGuirk, DO
Journal: Blood
Blood (2019) 134 (Supplement_1): 5743.
https://doi.org/10.1182/blood-2019-130828
Published: 2019
Journal Articles

Impact of Renal Dysfunction Measured By Estimated Glomerular Filtration Rate (eGFR) on Outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT)

Nosha Farhadfar, MD, Ajoy L. Dias, MD, Tao Wang, PhD, Caitrin Fretham, Hemant S. Murthy, MD, Brent R. Logan, Shin Mineishi, MD, Bipin N. Savani, MD, Edward A. Stadtmauer, MD FACP, Saurabh Chhabra, MD, John R. Wingard, MD, Siddhartha Ganguly, MD, Marcelo C. Pasquini, MDMS
Journal: Blood
Blood (2019) 134 (Supplement_1): 3256.
https://doi.org/10.1182/blood-2019-125761
Published: 2019
Journal Articles

Daratumumab, Pomalidomide, and Dexamethasone (DPd) As Salvage Treatment for Relapsed/Refractory Myeloma Eligible for High-Dose Chemotherapy/Autologous Stem Cell Transplantation

Al-Ola Abdallah, MD, Neil Dunavin, MD, Brian McClune, DO, Leyla Shune, MD, Ajoy L. Dias, MD, Zahra Mahmoudjafari, PhD, Erica Hochard, PhD, Joseph P. McGuirk, DO, Siddhartha Ganguly, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5760.
https://doi.org/10.1182/blood-2018-99-117654
Published: 2018
Journal Articles

Daratumumab, Pomalidomide, and Dexamethasone (DPd) for the Treatment of Relapsed/Refractory Multiple Myeloma: A Single Institution Experience

Al-Ola Abdallah, MD, Neil Dunavin, MD, Brian McClune, DO, Leyla Shune, MD, Ajoy L. Dias, MD, Zahra Mahmoudjafari, PhD, Erica Hochard, PhD, Joseph P. McGuirk, DO, Siddhartha Ganguly, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5642.
https://doi.org/10.1182/blood-2018-99-117497
Published: 2018
Journal Articles

Successful Management of Treatment-Emergent Chronic Graft-Versus-Host Disease of the Liver Following Nivolumab for Relapsed Hodgkin's Lymphoma after Allogeneic Stem Cell Transplant

Mitchell Braun, BS, Neil Dunavin, MD, Maxwell Pike, MD, Ajoy L. Dias, MD, Tara L. Lin, MD, Leyla Shune, MD, Siddhartha Ganguly, MD, Joseph P. McGuirk, DO, Anurag K. Singh, MD, Sunil Abhyankar, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5492.
https://doi.org/10.1182/blood.V130.Suppl_1.5492.5492
Published: 2017
Journal Articles

Chemotherapy-Refractory Acute Myeloid Leukemia and Outcomes after Allogeneic Stem Cell Transplantation—a Single Center Analysis

Kapil Kohli, MD, Ajoy L. Dias, MD, Neil Dunavin, MD, Leyla Shune, MD, Tara L. Lin, MD, Sunil Abhyankar, MD, Anurag K. Singh, MD, Siddhartha Ganguly, MD, Joseph P. McGuirk, DO, Barry S. Skikne, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5541.
https://doi.org/10.1182/blood.V130.Suppl_1.5541.5541
Published: 2017
Journal Articles

Incidence and Risk Factors of Epstein-Barr Virus Viremia in Patients Undergoing Haploidential Transplantation with Post Translant Cyclophosphamide

Ghulam Rehman Mohyuddin, MD, Shaun DeJarnette, Leyla Shune, MD, Tara L. Lin, MD, Neil Dunavin, MD, Ajoy L. Dias, MD, Siddhartha Ganguly, MD, Sunil Abhyankar, MD, Joseph P. McGuirk, DO, Anurag K. Singh, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5557.
https://doi.org/10.1182/blood.V130.Suppl_1.5557.5557
Published: 2017
Journal Articles

Clinical Outcome of Therapy-Related Acute Myeloid Leukemia Is Strongly Related to Cytogenetic Analysis

Croix Fossum, BS, Rhett P. Ketterling, MD, Lindsey E. Roeker, Ajoy L. Dias, MD, Michelle Elliott, MD, William J. Hogan, MBChB, Mark R. Litzow, MD, Aref Al-Kali, MD
Journal: Blood
Blood (2015) 126 (23): 1401.
https://doi.org/10.1182/blood.V126.23.1401.1401
Published: 2015
Journal Articles

Early T-Lymphocyte Chimerism Kinetics Is Influenced By Conditioning Regimen in Reduced Intensity Allogeneic Stem Cell Transplantation

Nosha Farhadfar, MD, Damlaj Moussab, MD, Ajoy L. Dias, MD, Hassan B Alkhateeb, MD, Mark R Litzow, MD, Shahrukh K. Hashmi, MD, Mrinal M Patnaik, MBBS, William J Hogan, MBChB
Journal: Blood
Blood (2015) 126 (23): 1923.
https://doi.org/10.1182/blood.V126.23.1923.1923
Published: 2015